Structure based on 4qw5 | Ideal structure |
|
Name: n-{(2s)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-l-leucyl-n-[(2r,3s,4s)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-l-phenylalaninamide |
Formula: C40 H61 N5 O7 |
Weight: 723.942 |
SMILES: "CC(C)C[CH](NC(=O)[CH](Cc1ccccc1)NC(=O)[CH](CC(C)C)NC(=O)[CH](CCc2ccccc2)NC(=O)CN3CCOCC3)[CH](O)[CH](C)CO" |
Spacial conformation based on PDB
4qw5. Also present in other
27 PDB entries. |
RESIDUE 3BV 113
CONECT C8 3 O9 C7 N10
CONECT O9 1 C8
CONECT C7 4 C8 N4 H5 H6
CONECT N4 3 C7 C5 C3
CONECT O1 2 C6 C2
CONECT C5 4 N4 C6 H1 H2
CONECT C3 4 N4 C2 H16 H17
CONECT C6 4 O1 C5 H3 H4
CONECT C2 4 O1 C3 H18 H19
CONECT N10 3 C8 C11 H21
CONECT C11 4 N10 C20 C12 H22
CONECT C20 3 C11 O21 N22
CONECT O21 1 C20
CONECT C12 4 C11 C13 H23 H24
CONECT C13 4 C12 C14 H7 H8
CONECT C14 3 C13 C19 C15
CONECT C19 3 C14 C18 H25
CONECT C15 3 C14 C16 H9
CONECT C18 3 C19 C17 H26
CONECT C16 3 C15 C17 H27
CONECT C17 3 C18 C16 H10
CONECT N22 3 C20 C23 H28
CONECT C23 4 N22 C28 C24 H29
CONECT C28 3 C23 O29 N30
CONECT O29 1 C28
CONECT C24 4 C23 C25 H11 H12
CONECT C25 4 C24 C26 C27 H30
CONECT C26 4 C25 H13 H14 H15
CONECT C27 4 C25 H31 H32 H33
CONECT N30 3 C28 C31 H34
CONECT C31 4 N30 C39 C32 H35
CONECT C39 3 C31 O40 N41
CONECT O40 1 C39
CONECT C32 4 C31 C33 H36 H37
CONECT C33 3 C32 C34 C38
CONECT C34 3 C33 C35 H42
CONECT C38 3 C33 C37 H38
CONECT C35 3 C34 C36 H41
CONECT C37 3 C38 C36 H39
CONECT C36 3 C35 C37 H40
CONECT N41 3 C39 C42 H43
CONECT C42 4 N41 C43 C47 H44
CONECT C43 4 C42 C44 H45 H46
CONECT C44 4 C43 C45 C46 H47
CONECT C45 4 C44 H48 H49 H50
CONECT C46 4 C44 H51 H52 H53
CONECT C47 4 C42 C51 O48 H54
CONECT C51 4 C47 C58 C59 H56
CONECT C58 4 C51 H57 H58 H59
CONECT C59 4 C51 O60 H60 H61
CONECT O60 2 C59 H62
CONECT O48 2 C47 H55
CONECT H5 1 C7
CONECT H6 1 C7
CONECT H1 1 C5
CONECT H2 1 C5
CONECT H16 1 C3
CONECT H17 1 C3
CONECT H3 1 C6
CONECT H4 1 C6
CONECT H18 1 C2
CONECT H19 1 C2
CONECT H21 1 N10
CONECT H22 1 C11
CONECT H23 1 C12
CONECT H24 1 C12
CONECT H7 1 C13
CONECT H8 1 C13
CONECT H25 1 C19
CONECT H9 1 C15
CONECT H26 1 C18
CONECT H27 1 C16
CONECT H10 1 C17
CONECT H28 1 N22
CONECT H29 1 C23
CONECT H11 1 C24
CONECT H12 1 C24
CONECT H30 1 C25
CONECT H13 1 C26
CONECT H14 1 C26
CONECT H15 1 C26
CONECT H31 1 C27
CONECT H32 1 C27
CONECT H33 1 C27
CONECT H34 1 N30
CONECT H35 1 C31
CONECT H36 1 C32
CONECT H37 1 C32
CONECT H42 1 C34
CONECT H38 1 C38
CONECT H41 1 C35
CONECT H39 1 C37
CONECT H40 1 C36
CONECT H43 1 N41
CONECT H44 1 C42
CONECT H45 1 C43
CONECT H46 1 C43
CONECT H47 1 C44
CONECT H48 1 C45
CONECT H49 1 C45
CONECT H50 1 C45
CONECT H51 1 C46
CONECT H52 1 C46
CONECT H53 1 C46
CONECT H54 1 C47
CONECT H56 1 C51
CONECT H57 1 C58
CONECT H58 1 C58
CONECT H59 1 C58
CONECT H60 1 C59
CONECT H61 1 C59
CONECT H62 1 O60
CONECT H55 1 O48
END
HET 3BV 113
HETSYN 3BV CARFILZOMIB, bound form
HETNAM 3BV N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoy
HETNAM 2 3BV l}-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylhep
HETNAM 3 3BV tan-4-yl]-L-phenylalaninamide
FORMUL 3BV C40 H61 N5 O7